West Pharmaceutical Services (WST) Finished Goods (2010 - 2012)

West Pharmaceutical Services has disclosed Finished Goods across 3 years of filings, most recently posting $65.3 million for Q2 2012.

• Finished Goods for Q2 2012 came in at $65.3 million, down 9.18% year-over-year; the trailing twelve-month figure through Jun 2012 was $65.3 million (down 9.18% YoY), and the FY2011 annual result was $67.1 million, up 3.07% from the prior year.
• Finished Goods came in at $65.3 million for Q2 2012 at West Pharmaceutical Services, down from $67.1 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $71.9 million in Q2 2011 to a low of $65.1 million in Q4 2010.
• The 3-year median for Finished Goods is $67.1 million (2011), against an average of $67.7 million.
• Across the five-year window, Finished Goods increased 3.07% in 2011 and retreated 9.18% in 2012, its largest moves.
• West Pharmaceutical Services' Finished Goods stood at $65.1 million in 2010, then climbed by 3.07% to $67.1 million in 2011, then decreased by 2.68% to $65.3 million in 2012.
• The last three Finished Goods figures came in at $65.3 million (Q2 2012), $67.1 million (Q4 2011), and $68.9 million (Q3 2011), per Business Quant data.